Cargando…

Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology

PURPOSE: Emerging evidence suggests G3 pancreatic neuroendocrine neoplasms (pNENs) present heterogeneous morphology and biology. The 2017 WHO classification has introduced a new category of well-differentiated pancreatic neuroendocrine tumors (WD-pNETs) G3, compared with poorly differentiated pancre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Xu, Xu, Xuefeng, Ma, Hongyun, Ji, Yuan, Wang, Dansong, Kuang, Tiantao, Wu, Wenchuan, Song, Bin, Li, Gang, Jin, Gang, Lou, Wenhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825924/ https://www.ncbi.nlm.nih.gov/pubmed/29472376 http://dx.doi.org/10.1530/EC-17-0388

Ejemplares similares

Prognostic role of lymphocyte-to-monocyte ratio in pancreatic neuroendocrine neoplasms
por: Zhou, Wentao, et al.
Publicado: (2020)

The Value of Alkaline Phosphatase-to-Albumin Ratio in Detecting Synchronous Metastases and Predicting Postoperative Relapses among Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms
por: Zhou, Wentao, et al.
Publicado: (2020)

Prognostic value of histological subtype in intraductal papillary mucinous neoplasm of the pancreas: A retrospective analysis of outcome from one single center
por: Rong, Yefei, et al.
Publicado: (2017)

GFAT1 is highly expressed in cancer stem cells of pancreatic cancer
por: Wang, Zhe, et al.
Publicado: (2022)

Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis
por: Xu, Yaolin, et al.
Publicado: (2022)

Circulating cytokines allow for identification of malignant intraductal papillary mucinous neoplasms of the pancreas
por: Pu, Ning, et al.
Publicado: (2022)

The value of systemic inflammatory markers in identifying malignancy in mucinous pancreatic cystic neoplasms
por: Zhou, Wentao, et al.
Publicado: (2017)

PYCR1: A Potential Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Wang, Huanyu, et al.
Publicado: (2022)

Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction
por: Pu, Ning, et al.
Publicado: (2019)

CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer
por: Pu, Ning, et al.
Publicado: (2018)

Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer
por: Yin, Hanlin, et al.
Publicado: (2021)

Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis
por: Zhou, Wentao, et al.
Publicado: (2019)

Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection
por: Pu, Ning, et al.
Publicado: (2017)

Clinicopathological Characteristics and Prognosis-Related Factors of Resectable Pancreatic Neuroendocrine Tumors: A Retrospective Study of 104 Cases in a Single Chinese Center
por: Han, Xu, et al.
Publicado: (2014)

Comprehensive Diagnostic Nomogram for Predicting Clinically Relevant Postoperative Pancreatic Fistula After Pancreatoduodenectomy
por: Li, Bo, et al.
Publicado: (2021)

Granulocytic sarcoma of the pancreas: A case report and review of the literatures
por: Rong, Yefei, et al.
Publicado: (2010)

Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma
por: Chen, Qiangda, et al.
Publicado: (2022)

Targeted deep sequencing reveals the genetic heterogeneity in well-differentiated pancreatic neuroendocrine tumors with liver metastasis
por: Zhou, Wentao, et al.
Publicado: (2022)

Clinical Analysis of Acinar Cell Carcinoma of the Pancreas: A Single-Center Experience of 45 Consecutive Cases
por: Zhou, Wentao, et al.
Publicado: (2020)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
por: La Rosa, Stefano
Publicado: (2021)

Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine
por: Rong, Yefei, et al.
Publicado: (2009)

Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?
por: Hijioka, Susumu, et al.
Publicado: (2014)

Should Steroid Therapy Be Necessarily Needed for Autoimmune Pancreatitis Patients with Lesion Resected due to Misdiagnosed or Suspected Malignancy?
por: Wu, Wenchuan, et al.
Publicado: (2014)

HEATR1 Deficiency Promotes Chemoresistance via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer
por: Fang, Yuan, et al.
Publicado: (2020)

Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage
por: De Robertis, Riccardo, et al.
Publicado: (2017)

Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study
por: Kim, Haeryoung, et al.
Publicado: (2020)

Imaging of Pancreatic Neuroendocrine Neoplasms
por: Chiti, Giuditta, et al.
Publicado: (2021)

Correlation between radiologic features on contrast-enhanced CT and pathological tumor grades in pancreatic neuroendocrine neoplasms
por: Xu, Wenbin, et al.
Publicado: (2021)

Role of surgical treatments in high-grade or advanced gastroenteropancreatic neuroendocrine neoplasms
por: Que, Qing-Yang, et al.
Publicado: (2022)

Current Role of Surgery in Pancreatic Cancer With Synchronous Liver Metastasis
por: Zhou, Wentao, et al.
Publicado: (2020)

Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2
por: Rong, Yefei, et al.
Publicado: (2010)

Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system
por: Zhang, Rihong, et al.
Publicado: (2022)

Surgical management of pancreatic neuroendocrine neoplasms
por: Partelli, Stefano, et al.
Publicado: (2014)

Imaging presentation of pancreatic neuroendocrine neoplasms
por: Ciaravino, Valentina, et al.
Publicado: (2018)

Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms
por: Zhuge, Xiaoling, et al.
Publicado: (2020)

An Insight on Functioning Pancreatic Neuroendocrine Neoplasms
por: Bevere, Michele, et al.
Publicado: (2023)

Management of Functional Pancreatic Neuroendocrine Neoplasms
por: Magi, Ludovica, et al.
Publicado: (2023)

Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors
por: Guo, Chuangen, et al.
Publicado: (2017)

Trends in Incidence and Survival of Patients with Pancreatic Neuroendocrine Neoplasm, 1987–2016
por: Wang, Jingxuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_repg4btnf3fh24gmlgrlvnje0i